Mycenax Biotech Inventory

Mycenax Biotech (4726.TWO) currently reports a inventory of $180M as of June 2026. That compares with $94M in the prior-year period — up 88.1% year over year. Use the charts on this page to explore Mycenax Biotech's inventory history and peer comparisons.

Mycenax Biotech's inventory increased from $94M to $180M — a 88.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mycenax Biotech reported $180M in inventory as of June 2026. That compares with $94M in the prior-year period — up 88.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mycenax Biotech, and consider following 4726.TWO for alerts when major investors trade the stock.

Mycenax Biotech is classified in the Healthcare sector. On inventory, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4726.TWO with unrelated industries.